董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Sarah Romano | 女 | Independent Director | 46 | 0.49万美元 | 未持股 | 2026-11-10 |
| Sammy Dorf | 男 | Chairman of the Board and Independent Director | 41 | 未披露 | 未持股 | 2026-11-10 |
| Josh Epstein | 男 | Independent Director | 47 | 未披露 | 未持股 | 2026-11-10 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David A. White | 男 | Chief Executive Officer | 73 | 未披露 | 未持股 | 2026-11-10 |
| Karina Fedasz | 女 | Interim Chief Financial Officer | 53 | 35.21万美元 | 未持股 | 2026-11-10 |
董事简历
中英对照 | 中文 | 英文- Sarah Romano
-
Sarah Romano在领导多家纳斯达克上市公司的金融职能方面拥有十多年的经验。Romano女士自2025年4月起担任手术机器人公司Vicarious Surgical Inc.（纽约证券交易所代码：RBOT）的首席财务官和财务主管。Romano女士此前于2022年3月至2025年3月担任Entero Therapeutics，Inc.（纳斯达克：ENTO）（前身为First Wave BioPharma Inc.）的首席财务官，该公司是一家临床阶段的生物制药公司，专门从事胃肠道疾病靶向口服给药疗法的开发。她此前曾于2017年2月至2022年2月期间担任Kiora Pharmaceuticals, Inc.（纳斯达克：KPRX）（前身为EyeGate Pharmaceuticals，Inc.）（一家开发治疗眼科疾病产品的临床阶段专科制药公司）的首席财务官，并于2016年8月至2017年1月担任公司控制人。在此之前，Romano女士于2015年6月至2016年8月期间担任TechTarget，Inc.的助理财务总监。Romano女士拥有圣十字学院会计学文学士学位和波士顿学院会计学硕士学位。
Sarah Romano has over a decade of experience leading the finance function of multiple Nasdaq listed companies. Ms. Romano has served as Chief Financial Officer and Treasurer of Vicarious Surgical Inc. (NYSE: RBOT), surgical robotics company, since April 2025. Ms. Romano previously served as the Chief Financial Officer of Entero Therapeutics, Inc. (Nasdaq: ENTO) (formerly First Wave BioPharma Inc.), a clinical stage biopharmaceutical company specializing in the development of targeted, orally delivered therapies for gastrointestinal diseases, from March 2022 to March 2025. She previously served as Chief Financial Officer of Kiora Pharmaceuticals, Inc. (Nasdaq: KPRX) (formerly EyeGate Pharmaceuticals, Inc.), a clinical stage specialty pharmaceutical company developing products for treating ophthalmic diseases, from February 2017 through February 2022, and as its Corporate Controller from August 2016 to January 2017. Before that, Ms. Romano served as Assistant Controller at TechTarget, Inc. from June 2015 through August 2016. Ms. Romano holds a Bachelor of Arts in Accounting from College of the Holy Cross and a Master of Accounting from Boston College. - Sarah Romano在领导多家纳斯达克上市公司的金融职能方面拥有十多年的经验。Romano女士自2025年4月起担任手术机器人公司Vicarious Surgical Inc.（纽约证券交易所代码：RBOT）的首席财务官和财务主管。Romano女士此前于2022年3月至2025年3月担任Entero Therapeutics，Inc.（纳斯达克：ENTO）（前身为First Wave BioPharma Inc.）的首席财务官，该公司是一家临床阶段的生物制药公司，专门从事胃肠道疾病靶向口服给药疗法的开发。她此前曾于2017年2月至2022年2月期间担任Kiora Pharmaceuticals, Inc.（纳斯达克：KPRX）（前身为EyeGate Pharmaceuticals，Inc.）（一家开发治疗眼科疾病产品的临床阶段专科制药公司）的首席财务官，并于2016年8月至2017年1月担任公司控制人。在此之前，Romano女士于2015年6月至2016年8月期间担任TechTarget，Inc.的助理财务总监。Romano女士拥有圣十字学院会计学文学士学位和波士顿学院会计学硕士学位。
- Sarah Romano has over a decade of experience leading the finance function of multiple Nasdaq listed companies. Ms. Romano has served as Chief Financial Officer and Treasurer of Vicarious Surgical Inc. (NYSE: RBOT), surgical robotics company, since April 2025. Ms. Romano previously served as the Chief Financial Officer of Entero Therapeutics, Inc. (Nasdaq: ENTO) (formerly First Wave BioPharma Inc.), a clinical stage biopharmaceutical company specializing in the development of targeted, orally delivered therapies for gastrointestinal diseases, from March 2022 to March 2025. She previously served as Chief Financial Officer of Kiora Pharmaceuticals, Inc. (Nasdaq: KPRX) (formerly EyeGate Pharmaceuticals, Inc.), a clinical stage specialty pharmaceutical company developing products for treating ophthalmic diseases, from February 2017 through February 2022, and as its Corporate Controller from August 2016 to January 2017. Before that, Ms. Romano served as Assistant Controller at TechTarget, Inc. from June 2015 through August 2016. Ms. Romano holds a Bachelor of Arts in Accounting from College of the Holy Cross and a Master of Accounting from Boston College.
- Sammy Dorf
-
Sammy Dorf是Verano Holdings Corp.（“Verano”）的联合创始人和前首席增长官，Verano Holdings Corp.（“Verano”）是一家垂直整合的美国大麻公司，根据最新的年度报告期，该公司的收入超过9.25亿美元。他在2015年10月至2024年3月期间与Verano在一起。2023年11月至今，为Dreamlife Consulting创始人。他在Verano的发展中发挥了重要作用；他的成就包括筹集资金，在14个州获得40多个许可证，并在伊利诺伊州、马里兰州、内华达州、宾夕法尼亚州和俄亥俄州等市场建立业务。一名刑事辩护律师成为大麻企业家；他在大麻领域的许多交易中发挥了关键作用。多尔夫先生入选了High Times 100。该奖项是由大麻出版物High Times创立的，旨在表彰目前影响和积极塑造大麻商业、技术、科学、健康和创新的男性和女性所取得的非凡进步和努力。
Sammy Dorf joined the Board on November 10, 2025. Mr. Dorf currently serves as the Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC). Prior to joining Flora, Sammy was the Co Founder and Chief Growth Officer of Verano Holdings, one of the most successful multi state cannabis companies in the United States, from 2015 to 2021. At Verano, Mr. Dorf was instrumental in the company's evolution from a start up into a national porhoe known for its premium products, operational sophistication, and award winning brands.. To date, Mr. Dorf has successfully raised over $300 million in capital and secured more than 25 licenses across 14 states. Beyond the cannabis sector, Sammy has also demonstrated deep expertise in cryptocurrency investments, treasury management, and alternative asset strategy, helping companies optimize liquidity, hedge exposure, and build resilient portfolios in emerging financial ecosystems. - Sammy Dorf是Verano Holdings Corp.（“Verano”）的联合创始人和前首席增长官，Verano Holdings Corp.（“Verano”）是一家垂直整合的美国大麻公司，根据最新的年度报告期，该公司的收入超过9.25亿美元。他在2015年10月至2024年3月期间与Verano在一起。2023年11月至今，为Dreamlife Consulting创始人。他在Verano的发展中发挥了重要作用；他的成就包括筹集资金，在14个州获得40多个许可证，并在伊利诺伊州、马里兰州、内华达州、宾夕法尼亚州和俄亥俄州等市场建立业务。一名刑事辩护律师成为大麻企业家；他在大麻领域的许多交易中发挥了关键作用。多尔夫先生入选了High Times 100。该奖项是由大麻出版物High Times创立的，旨在表彰目前影响和积极塑造大麻商业、技术、科学、健康和创新的男性和女性所取得的非凡进步和努力。
- Sammy Dorf joined the Board on November 10, 2025. Mr. Dorf currently serves as the Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC). Prior to joining Flora, Sammy was the Co Founder and Chief Growth Officer of Verano Holdings, one of the most successful multi state cannabis companies in the United States, from 2015 to 2021. At Verano, Mr. Dorf was instrumental in the company's evolution from a start up into a national porhoe known for its premium products, operational sophistication, and award winning brands.. To date, Mr. Dorf has successfully raised over $300 million in capital and secured more than 25 licenses across 14 states. Beyond the cannabis sector, Sammy has also demonstrated deep expertise in cryptocurrency investments, treasury management, and alternative asset strategy, helping companies optimize liquidity, hedge exposure, and build resilient portfolios in emerging financial ecosystems.
- Josh Epstein
-
Josh Epstein是一名高级管理人员和法律专业人士，在能源、采矿、技术、医疗保健、大麻、区块链、游戏和自主系统行业拥有超过20年的经验。自2025年12月以来，他曾在Mariana Minerals Co.（一家采矿技术公司）担任企业发展、资本市场和法律职务，该公司开发人工智能驱动的软件和自主操作系统，旨在优化矿物加工、矿山运营和跨生产资产的资本部署。在该职位上，他为C套件提供有关企业发展、资本市场战略、并购、合伙结构和交易执行方面的建议。自2025年10月起，Epstein先生担任SRX Health Solutions，Inc.（NYSE American：SRXH）的董事会成员。从2024年11月到2025年12月，Epstein先生担任Lisbon Valley Mining Co.的企业发展主管和管理委员会成员，负责监督犹他州东南部生产铜矿的所有资本市场、并购、合作伙伴关系和其他交易活动。此前，从2021年3月到2024年11月，Epstein先生是JJR Private Capital的顾问，这是一家成立于2003年、位于佛罗里达州和多伦多的私募股权公司。此前，Epstein先生曾担任Socati Corp.的首席执行官和董事，该公司是一家垂直整合的成分和消费品制造商，面向全球大麻素和健康市场。在加入Socati之前，Epstein先生曾担任Nuuvera Inc.的总裁兼首席运营官，该公司是一家国际健康和医用大麻公司，成立于2016年，后来在多伦多证券交易所上市– V，并于2018年出售给Tilray Inc.（纳斯达克股票代码：TLRY）（前身为Aphria Inc.）。Epstein此前是FastForward Innovations Ltd.的合伙人，该公司是一家早期风险投资公司，负责监督该公司在美国、加拿大、英国、德国、以色列和中国的投资组合公司的投资和资产剥离。Epstein先生的职业生涯始于国际律师事务所Baker Botts，LLP，他的执业重点是并购、风险投资和证券发行。Epstein先生拥有得克萨斯大学的学士学位（英语，荣誉课程）和学士学位（金融）、得克萨斯大学法学院的京东，并以荣誉和得克萨斯法律评论的成员身份毕业，以及得克萨斯奥斯汀阿克顿商学院的MBA学位，并在那里担任班级的告别演说者。
Josh Epstein is a senior executive and legal professional with more than 20 years of experience across the energy, mining, technology, healthcare, cannabis, blockchain, gaming, and autonomous systems industries. Since December 2025, he has served in a Corporate Development, Capital Markets and Legal role at Mariana Minerals Co., a mining technology company developing AI powered software and autonomous operating systems designed to optimize mineral processing, mine operations, and capital deployment across producing assets. In that capacity, he advises the C suite on corporate development, capital markets strategy, mergers and acquisitions, partnership structuring, and transaction execution. Since October 2025, Mr. Epstein has served as a Board Member of SRx Health Solutions, Inc. (NYSE American: SRXH). From November of 2024 to December of 2025, Mr. Epstein was the head of Corporate Development and on the Board of Managers for Lisbon Valley Mining Co., overseeing all capital markets, M&A, partnership, and other transactional activities for the producing copper mine in Southeast Utah. Formerly, from March 2021 to November 2024, Mr. Epstein was a consultant to JJR Private Capital, a Florida and Toronto based private equity firm founded in 2003. Previously, Mr. Epstein served as the CEO and Director of Socati Corp., a vertically integrated manufacturer of ingredients and consumer products for global cannabinoid and wellness markets. Prior to Socati, Mr. Epstein served as President and COO of Nuuvera Inc., an international wellness and medical cannabis company founded in 2016 that later listed on the Toronto Stock Exchange–V and sold to Tilray Inc. (NASDAQ: TLRY) (formerly Aphria Inc.) in 2018. Mr. Epstein was previously a Partner with FastForward Innovations Ltd., an early stage venture capital firm where he oversaw investments and divestitures of the firm's portfolio companies in the United States, Canada, the United Kingdom, Germany, Israel and China. Mr. Epstein began his career as an attorney with the international law firm Baker Botts, LLP, where his practice focused on mergers and acquisitions, venture capital and securities offerings. Mr. Epstein holds a B.A (English, Honors Program) and B.B.A. (Finance) from the University of Texas, a JD from the University of Texas School of Law, where he graduated with Honors and as a member of the Texas Law Review, and an MBA from the Acton School of Business in Austin, Texas, where he was valedictorian of his class. - Josh Epstein是一名高级管理人员和法律专业人士，在能源、采矿、技术、医疗保健、大麻、区块链、游戏和自主系统行业拥有超过20年的经验。自2025年12月以来，他曾在Mariana Minerals Co.（一家采矿技术公司）担任企业发展、资本市场和法律职务，该公司开发人工智能驱动的软件和自主操作系统，旨在优化矿物加工、矿山运营和跨生产资产的资本部署。在该职位上，他为C套件提供有关企业发展、资本市场战略、并购、合伙结构和交易执行方面的建议。自2025年10月起，Epstein先生担任SRX Health Solutions，Inc.（NYSE American：SRXH）的董事会成员。从2024年11月到2025年12月，Epstein先生担任Lisbon Valley Mining Co.的企业发展主管和管理委员会成员，负责监督犹他州东南部生产铜矿的所有资本市场、并购、合作伙伴关系和其他交易活动。此前，从2021年3月到2024年11月，Epstein先生是JJR Private Capital的顾问，这是一家成立于2003年、位于佛罗里达州和多伦多的私募股权公司。此前，Epstein先生曾担任Socati Corp.的首席执行官和董事，该公司是一家垂直整合的成分和消费品制造商，面向全球大麻素和健康市场。在加入Socati之前，Epstein先生曾担任Nuuvera Inc.的总裁兼首席运营官，该公司是一家国际健康和医用大麻公司，成立于2016年，后来在多伦多证券交易所上市– V，并于2018年出售给Tilray Inc.（纳斯达克股票代码：TLRY）（前身为Aphria Inc.）。Epstein此前是FastForward Innovations Ltd.的合伙人，该公司是一家早期风险投资公司，负责监督该公司在美国、加拿大、英国、德国、以色列和中国的投资组合公司的投资和资产剥离。Epstein先生的职业生涯始于国际律师事务所Baker Botts，LLP，他的执业重点是并购、风险投资和证券发行。Epstein先生拥有得克萨斯大学的学士学位（英语，荣誉课程）和学士学位（金融）、得克萨斯大学法学院的京东，并以荣誉和得克萨斯法律评论的成员身份毕业，以及得克萨斯奥斯汀阿克顿商学院的MBA学位，并在那里担任班级的告别演说者。
- Josh Epstein is a senior executive and legal professional with more than 20 years of experience across the energy, mining, technology, healthcare, cannabis, blockchain, gaming, and autonomous systems industries. Since December 2025, he has served in a Corporate Development, Capital Markets and Legal role at Mariana Minerals Co., a mining technology company developing AI powered software and autonomous operating systems designed to optimize mineral processing, mine operations, and capital deployment across producing assets. In that capacity, he advises the C suite on corporate development, capital markets strategy, mergers and acquisitions, partnership structuring, and transaction execution. Since October 2025, Mr. Epstein has served as a Board Member of SRx Health Solutions, Inc. (NYSE American: SRXH). From November of 2024 to December of 2025, Mr. Epstein was the head of Corporate Development and on the Board of Managers for Lisbon Valley Mining Co., overseeing all capital markets, M&A, partnership, and other transactional activities for the producing copper mine in Southeast Utah. Formerly, from March 2021 to November 2024, Mr. Epstein was a consultant to JJR Private Capital, a Florida and Toronto based private equity firm founded in 2003. Previously, Mr. Epstein served as the CEO and Director of Socati Corp., a vertically integrated manufacturer of ingredients and consumer products for global cannabinoid and wellness markets. Prior to Socati, Mr. Epstein served as President and COO of Nuuvera Inc., an international wellness and medical cannabis company founded in 2016 that later listed on the Toronto Stock Exchange–V and sold to Tilray Inc. (NASDAQ: TLRY) (formerly Aphria Inc.) in 2018. Mr. Epstein was previously a Partner with FastForward Innovations Ltd., an early stage venture capital firm where he oversaw investments and divestitures of the firm's portfolio companies in the United States, Canada, the United Kingdom, Germany, Israel and China. Mr. Epstein began his career as an attorney with the international law firm Baker Botts, LLP, where his practice focused on mergers and acquisitions, venture capital and securities offerings. Mr. Epstein holds a B.A (English, Honors Program) and B.B.A. (Finance) from the University of Texas, a JD from the University of Texas School of Law, where he graduated with Honors and as a member of the Texas Law Review, and an MBA from the Acton School of Business in Austin, Texas, where he was valedictorian of his class.
高管简历
中英对照 | 中文 | 英文- David A. White
DavidA.White自2012年5月以来一直担任First Call Services LLC（一家私人控股公司和咨询公司）的普通合伙人兼总裁兼首席执行官。他任职于AG Growth International Inc.（多伦多证券交易所农场设备制造商）、Patient Care Logistics Solutions（私人股本赞助公司）和Avicanna Inc.（加拿大生物技术公司）的董事会。他曾于2015年至2018年7月担任美国私营公司昇兴股份Transportation Holdings LLC的董事会成员。White先生曾在John Labatt Limited，Lawson Mardon Group Inc.和Laidlaw Inc.担任多个高级财务和运营职位，最近担任TransCare Inc.的首席执行官，这是一家医疗运输公司，2008年至2012年4月，2005年至2007年，担任TSX上市公司Student Transportation of America的总裁兼首席运营官。White先生自1978年以来一直是加拿大注册会计师，他持有西安大略大学的文学学士学位和多伦多大学的工商管理硕士学位，并于2013年获得公司董事协会的ICD.D指定。White先生于2016年12月被任命为董事会成员，目前担任审计和薪酬委员会成员。
David A. White is a corporate director and currently the General Partner of First Call Services LLC, a private holding company and advisory firm. He has held a number of senior financial and operating positions with John Labatt Limited, Lawson Mardon Group Inc., and Laidlaw Inc., and was Chief Executive Officer of American Student Transportation Partners, a provider of student transportation services, Chief Executive Officer of TransCare Inc., a medical transportation company, and President and Chief Operating Officer of Student Transportation of America, formerly a TSX listed company. He also served on the board of directors for Ag Growth International Inc., a Toronto Stock Exchange listed farm equipment manufacturer. Mr. White has been a Canadian Charted Accountant since 1978, he holds a BA from the University of stern Ontario and an MBA from the University of Toronto, and in 2013 he received the ICD.D designation from the Institute of Corporate Directors. Mr. White was appointed to the Board in December 2016 and currently serves as a member of the Audit and Chair of the Compensation Committees.- DavidA.White自2012年5月以来一直担任First Call Services LLC（一家私人控股公司和咨询公司）的普通合伙人兼总裁兼首席执行官。他任职于AG Growth International Inc.（多伦多证券交易所农场设备制造商）、Patient Care Logistics Solutions（私人股本赞助公司）和Avicanna Inc.（加拿大生物技术公司）的董事会。他曾于2015年至2018年7月担任美国私营公司昇兴股份Transportation Holdings LLC的董事会成员。White先生曾在John Labatt Limited，Lawson Mardon Group Inc.和Laidlaw Inc.担任多个高级财务和运营职位，最近担任TransCare Inc.的首席执行官，这是一家医疗运输公司，2008年至2012年4月，2005年至2007年，担任TSX上市公司Student Transportation of America的总裁兼首席运营官。White先生自1978年以来一直是加拿大注册会计师，他持有西安大略大学的文学学士学位和多伦多大学的工商管理硕士学位，并于2013年获得公司董事协会的ICD.D指定。White先生于2016年12月被任命为董事会成员，目前担任审计和薪酬委员会成员。
- David A. White is a corporate director and currently the General Partner of First Call Services LLC, a private holding company and advisory firm. He has held a number of senior financial and operating positions with John Labatt Limited, Lawson Mardon Group Inc., and Laidlaw Inc., and was Chief Executive Officer of American Student Transportation Partners, a provider of student transportation services, Chief Executive Officer of TransCare Inc., a medical transportation company, and President and Chief Operating Officer of Student Transportation of America, formerly a TSX listed company. He also served on the board of directors for Ag Growth International Inc., a Toronto Stock Exchange listed farm equipment manufacturer. Mr. White has been a Canadian Charted Accountant since 1978, he holds a BA from the University of stern Ontario and an MBA from the University of Toronto, and in 2013 he received the ICD.D designation from the Institute of Corporate Directors. Mr. White was appointed to the Board in December 2016 and currently serves as a member of the Audit and Chair of the Compensation Committees.
- Karina Fedasz
Karina Fedasz帮助企业筹集资金、对业务进行建模和预测、管理现金流并进行并购。从2023年1月到2024年6月，Fedasz女士与多个客户合作，包括一个非盈利和早期人工智能和数据驱动的健康和保健跟踪器。从2022年2月到2022年12月，Fedasz女士担任Evofem Biosciences的业务发展主管，该公司是一家在纳斯达克上市的上市生物技术公司，为女性健康开发创新产品。从2019年8月到2021年10月，Fedasz女士在微盘媒体公司IDW Media Holdings担任过各种职责不断增加的职位，包括首席财务官，在那里她管理着该公司的首次公开发行。2018年4月至2019年8月，Fedasz女士担任MOCEAN的首席财务官，MOCEAN是一家娱乐、游戏和品牌的综合机构。Fedasz女士的广泛经验见证了她在媒体、技术、服务、制造和教育领域的领导团队，她曾与客户和客户包括Netflix、迪士尼、亚马逊、苹果、动视和EA等财富500强公司的公司合作。Fedasz女士获得了哥伦比亚大学商学院的金融MBA学位和加州大学洛杉矶分校（UCLA）的学士学位。她在加利福尼亚州拥有一名非在职注册会计师。
Karina Fedasz has helped companies raise capital, model and forecast business, manage cash flow and conduct mergers and acquisitions. From January 2023 to June 2024, Ms. Fedasz worked with various clients, including a not for profit and an early stage artificial intelligence and data driven health and wellness tracker. From February 2022 to December 2022, Ms. Fedasz served as Head of Business Development for Evofem Biosciences, a Nasdaq listed public biotech company developing innovative products for women's health. From August 2019 to October 2021, Ms. Fedasz served in various positions of increasing responsibility, including Chief Financial Officer, at IDW Media Holdings, a micro cap media company, where she managed the company's initial public offering. From April 2018 to August 2019, Ms. Fedasz served as Chief Financial Officer of MOCEAN, an integrated agency for entertainment, gaming, and brands. Ms. Fedasz's breadth of experience has seen her lead teams in media, technology, services, manufacturing, and education, and she has worked with companies whose clients and customers include Fortune 500 companies such as Netflix, Disney, Amazon, Apple, Activision, and EA. Ms. Fedasz received an MBA with an emphasis in finance from Columbia Business School and a BA from University California at Los Angeles (UCLA). She holds an inactive CPA in the state of California.- Karina Fedasz帮助企业筹集资金、对业务进行建模和预测、管理现金流并进行并购。从2023年1月到2024年6月，Fedasz女士与多个客户合作，包括一个非盈利和早期人工智能和数据驱动的健康和保健跟踪器。从2022年2月到2022年12月，Fedasz女士担任Evofem Biosciences的业务发展主管，该公司是一家在纳斯达克上市的上市生物技术公司，为女性健康开发创新产品。从2019年8月到2021年10月，Fedasz女士在微盘媒体公司IDW Media Holdings担任过各种职责不断增加的职位，包括首席财务官，在那里她管理着该公司的首次公开发行。2018年4月至2019年8月，Fedasz女士担任MOCEAN的首席财务官，MOCEAN是一家娱乐、游戏和品牌的综合机构。Fedasz女士的广泛经验见证了她在媒体、技术、服务、制造和教育领域的领导团队，她曾与客户和客户包括Netflix、迪士尼、亚马逊、苹果、动视和EA等财富500强公司的公司合作。Fedasz女士获得了哥伦比亚大学商学院的金融MBA学位和加州大学洛杉矶分校（UCLA）的学士学位。她在加利福尼亚州拥有一名非在职注册会计师。
- Karina Fedasz has helped companies raise capital, model and forecast business, manage cash flow and conduct mergers and acquisitions. From January 2023 to June 2024, Ms. Fedasz worked with various clients, including a not for profit and an early stage artificial intelligence and data driven health and wellness tracker. From February 2022 to December 2022, Ms. Fedasz served as Head of Business Development for Evofem Biosciences, a Nasdaq listed public biotech company developing innovative products for women's health. From August 2019 to October 2021, Ms. Fedasz served in various positions of increasing responsibility, including Chief Financial Officer, at IDW Media Holdings, a micro cap media company, where she managed the company's initial public offering. From April 2018 to August 2019, Ms. Fedasz served as Chief Financial Officer of MOCEAN, an integrated agency for entertainment, gaming, and brands. Ms. Fedasz's breadth of experience has seen her lead teams in media, technology, services, manufacturing, and education, and she has worked with companies whose clients and customers include Fortune 500 companies such as Netflix, Disney, Amazon, Apple, Activision, and EA. Ms. Fedasz received an MBA with an emphasis in finance from Columbia Business School and a BA from University California at Los Angeles (UCLA). She holds an inactive CPA in the state of California.